MiRNA-21, a critical mediator of inflammation that upregulates interleukin-6- and NF-κB-associated pathways and modulates lymphocyte signaling, was one of the first identified microRNAs associated with LN [28,29,30,31]. Here, NFKB1 is linked to lobular neoplasia.